Recurring thrombocytopenia associated with structured treatment interruption in patients with human immunodeficiency virus infection

27Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In a structured treatment interruption (STI) trial, 3 of 23 patients in a CD4 cell count-guided treatment arm developed recurring thrombocytopenia associated with the interruption of antiretroviral therapy. All 3 patients had slightly low or normal platelet counts before initiating antiretroviral therapy. STI may play a role in inducing thrombocytopenia in patients with human immunodeficiency virus infection.

Cite

CITATION STYLE

APA

Ananworanich, J., Phanuphak, N., Nuesch, R., Apateerapong, W., Rojnuckarin, P., Ubolyam, S., … Ruxrungtham, K. (2003). Recurring thrombocytopenia associated with structured treatment interruption in patients with human immunodeficiency virus infection. Clinical Infectious Diseases, 37(5), 723–725. https://doi.org/10.1086/376989

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free